Seasonal allergic rhinitis, commonly known as hay fever, is an allergic inflammatory disease of the nasal airways affecting millions worldwide. It occurs when an individual's immune system overreacts to allergens like pollen and mold that are inhaled. Common symptoms include sneezing, nasal congestion, runny nose and itchy/watery eyes. The seasonal allergic rhinitis market comprises drugs for prevention and treatment of hay fever such as oral antihistamines, intranasal corticosteroids, decongestants. Easy accessibility and non-invasive nature of treatment options like antihistamines increases their usage and preference over other pharmaceutical therapies. The rising global air pollution levels are causing an upsurge in the number of allergic cases adding to the market growth.
The Seasonal Allergic Rhinitis Market is estimated to be valued at US$ 10.8 Bn in 2024 and is expected to exhibit a CAGR of 2.9% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the seasonal allergic rhinitis are Regeneron Pharmaceuticals,Revolo Biotherapeutics, Allergy Therapeutics, Emergo Therapeutics, ALKAbello. Regeneron Pharmaceuticals leads the market with its top-selling monoclonal antibody drug Dupixent used to treat symptoms.
The market offers huge opportunities for new product development and innovation. Companies are investing in R&D of advanced therapeutic technologies like immunotherapy, DNA vaccines, and sublingual and epicutaneous immunotherapy to provide long-term relief.
Globally, seasonal allergic rhinitis prevalence is expanding beyond traditional Western markets into Eastern Europe, Asia Pacific and Latin America due to changes in climate, environment and lifestyle. Major players are targeting these emerging economies through tailored clinical studies, awareness campaigns and affordable drug delivery.
Market Drivers
The major market driver is increasing prevalence of allergic diseases and sensitization worldwide due to pollution, lifestyle changes and environmental factors. According to WHO, over 300 million people currently suffer from seasonal allergic rhinitis globally.
Market Restrains
A key challenge impeding market potential is affordability of advanced prescription drugs in developing countries. Also, alternative treatment options like natural remedies limit full reliance on pharmaceutical products. Finally, stringent regulatory oversight over pricing of newly developed therapies adds uncertainty.
Segment Analysis
The seasonal allergic rhinitis market is segmented on the basis of drug class, type of treatment and route of administration. By drug class it is segmented into antihistamines, decongestants, corticosteroids, intranasal anticholinergics and immunotherapies. Antihistamines dominate the market accounting for over 30% share owing to its efficacy and easy availability across all distribution channels. By type of treatment, the market is segmented into pharmacotherapy and immunotherapy. Pharmacotherapy leads with over 70% share due to its immediate relief from symptoms and higher preference by patients. Segmentation based on route of administration includes oral, nasal and others. Oral dominates as it offers convenience of intake along with rapid absorption.
Global Analysis
Regionally, North America dominates the seasonal allergic rhinitis market. It accounts for around 35% of the global market share. High awareness about allergies and availability of advanced treatment options are key factors responsible for its leading position. Meanwhile, Asia Pacific is recognized as the fastest growing regional market projected to witness a CAGR of over 5% during the forecast period. Increasing pollution levels, changing lifestyles and growing healthcare expenditure are some factors fueling the demand. Countries like India, China, and Japan are expected to be at the forefront of this regional market. Europe captures the second largest market share supported by substantial research funding and R&D investments from leading industry players within the region.
Get more insights on this topic: https://pressreleasebulletin.com/seasonal-allergic-rhinitis-market-is-driven-by-widespread-seasonal-allergen-pollen-exposure/
Author Bio:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights. (LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )
What Are The Key Data Covered In This Seasonal Allergic Rhinitis Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Seasonal Allergic Rhinitis Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Seasonal Allergic Rhinitis Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Seasonal Allergic Rhinitis Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Seasonal Allergic Rhinitis Market vendors
FAQ’s
Q.1 What are the main factors influencing the Seasonal Allergic Rhinitis Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Seasonal Allergic Rhinitis Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Seasonal Allergic Rhinitis Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it